Just a moment...
Press 'Enter' to add multiple search terms. Rules for Better Search
Use comma for multiple locations.
---------------- For section wise search only -----------------
Accuracy Level ~ 90%
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
Issues: Whether the defendants' mark "Medisprin" was deceptively similar to the plaintiffs' registered mark "Disprin" so as to amount to infringement and passing off, and whether the surrounding factors of the nature of the goods, packing, mode of sale and Schedule H status gave rise to a likelihood of deception or confusion.
Analysis: The governing test under Section 2(1)(d) of the Trade and Merchandise Marks Act, 1958 is whether the rival mark so nearly resembles the registered mark as to be likely to deceive or cause confusion, judged by the overall impression of the mark and not by microscopic comparison. Applying that test, the mark "Medisprin" was held to be visually, phonetically and structurally different from "Disprin" because it begins with a different prefix and is pronounced differently as a whole. The Court also treated the products as different in nature, since the defendants' product was a coronary vasodilator for heart and vascular ailments, while the plaintiffs' product was an analgesic for common ailments. The packing, price and mode of marketing were also found to be dissimilar, and the Schedule H character of the defendants' product supported the absence of likely confusion.
Conclusion: The mark "Medisprin" was not deceptively similar to "Disprin", and no likelihood of confusion or passing off was established; the request for interim restraint failed.